A detailed history of Fred Alger Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Fred Alger Management, LLC holds 30,536 shares of EXAS stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,536
Holding current value
$1.81 Million
% of portfolio
0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $1.3 Million - $2.16 Million
30,536 New
30,536 $2.08 Million
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $5.38 Million - $7.05 Million
-95,628 Reduced 91.7%
8,654 $597,000
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $2.79 Million - $3.58 Million
47,263 Added 82.89%
104,282 $7.71 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $3.52 Million - $5.29 Million
-53,405 Reduced 48.36%
57,019 $3.89 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $5.07 Million - $7.68 Million
80,848 Added 273.36%
110,424 $10.4 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $1.4 Million - $2.09 Million
29,576 New
29,576 $2.01 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $2.76 Million - $3.8 Million
-30,616 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $15.2 Million - $22.6 Million
-162,480 Reduced 84.14%
30,616 $3.81 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $717,488 - $954,086
-6,155 Reduced 3.09%
193,096 $25.4 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $12.5 Million - $17.8 Million
125,083 Added 168.65%
199,251 $26.4 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $1.18 Million - $1.64 Million
16,116 Added 27.76%
74,168 $7.56 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $325,189 - $541,010
5,833 Added 11.17%
58,052 $5.05 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $296,946 - $818,287
-7,835 Reduced 13.05%
52,219 $3.03 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $48.5 Million - $62.3 Million
-624,641 Reduced 91.23%
60,054 $5.55 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $852,550 - $1.16 Million
-9,434 Reduced 1.36%
684,695 $61.9 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $445,312 - $587,249
-4,975 Reduced 0.71%
694,129 $81.9 Million
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $3.76 Million - $5.86 Million
-60,710 Reduced 7.99%
699,104 $60.6 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $4.48 Million - $6.61 Million
-80,011 Reduced 9.53%
759,814 $47.9 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $24.7 Million - $41.2 Million
-510,821 Reduced 37.82%
839,825 $66.3 Million
Q2 2018

Jul 19, 2018

SELL
$37.84 - $69.96 $56.5 Million - $105 Million
-1,494,242 Reduced 52.52%
1,350,646 $80.8 Million
Q1 2018

May 10, 2018

BUY
$39.82 - $57.53 $42.9 Million - $61.9 Million
1,076,357 Added 60.86%
2,844,888 $115 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $13.6 Million - $17.7 Million
-291,871 Reduced 14.17%
1,768,531 $92.9 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $76.3 Million - $97.1 Million
2,060,402
2,060,402 $97.1 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.